当前位置:首页 - 行情中心 - 惠泰医疗(688617) - 财务分析 - 现金流量表

惠泰医疗

(688617)

  

流通市值:330.33亿  总市值:330.33亿
流通股本:1.41亿   总股本:1.41亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金828,161,216.72,877,820,327.032,073,511,335.261,348,601,398.07
  收到的税费返还1,594,167.0212,095,630.098,785,554.335,671,213.23
  收到其他与经营活动有关的现金10,910,125.5984,968,721.3960,906,421.6444,101,599.56
  经营活动现金流入小计840,665,509.312,974,884,678.512,143,203,311.231,398,374,210.86
  购买商品、接受劳务支付的现金140,287,811.71560,908,178.76390,642,573.11212,426,422.92
  支付给职工以及为职工支付的现金292,872,952.57652,711,882.34507,275,957.58363,668,530.68
  支付的各项税费110,594,955.6343,299,570.66238,367,057.51158,840,953.71
  支付其他与经营活动有关的现金104,712,847.91450,205,387.97330,858,523.57218,789,650.62
  经营活动现金流出小计648,468,567.792,007,125,019.731,467,144,111.77953,725,557.93
  经营活动产生的现金流量净额192,196,941.52967,759,658.78676,059,199.46444,648,652.93
二、投资活动产生的现金流量:
  收回投资收到的现金506,505,643.852,515,428,765.891,731,078,765.881,210,078,765.88
  取得投资收益收到的现金1,760,068.527,542,413.54,564,016.422,811,829.37
  处置固定资产、无形资产和其他长期资产收回的现金净额55,600223,15070,53042,330
  投资活动现金流入小计508,321,312.372,523,194,329.391,735,713,312.31,212,932,925.25
  购建固定资产、无形资产和其他长期资产支付的现金64,998,258.32285,589,236.87233,491,613.4156,864,010.4
  投资支付的现金547,500,0002,738,500,0002,096,000,0001,322,000,000
  支付其他与投资活动有关的现金-18,287,481.34--
  投资活动现金流出小计612,498,258.323,042,376,718.212,329,491,613.41,478,864,010.4
  投资活动产生的现金流量净额-104,176,945.95-519,182,388.82-593,778,301.1-265,931,085.15
三、筹资活动产生的现金流量:
  吸收投资收到的现金985,437.335,936,123.8129,776,853.7820,873,979.28
  其中:子公司吸收少数股东投资收到的现金--8,902,874.5-
  取得借款收到的现金-4,000,0004,000,0004,000,000
  收到其他与筹资活动有关的现金5,000,00015,000,00010,000,0002,500,000
  筹资活动现金流入小计5,985,437.354,936,123.8143,776,853.7827,373,979.28
  偿还债务支付的现金3,920,000671,000671,000591,000
  分配股利、利润或偿付利息支付的现金5,292170,270,015.69170,243,255.69170,250,745.13
  支付其他与筹资活动有关的现金352,734,401.2163,738,987.1160,500,862.6353,224,424.28
  筹资活动现金流出小计356,659,693.2334,680,002.8231,415,118.32224,066,169.41
  筹资活动产生的现金流量净额-350,674,255.9-279,743,878.99-187,638,264.54-196,692,190.13
四、汇率变动对现金及现金等价物的影响-6,876,599.69-3,790,697.36-876,175.642,149,549.56
五、现金及现金等价物净增加额-269,530,860.02165,042,693.61-106,233,541.82-15,825,072.79
  加:期初现金及现金等价物余额1,246,130,604.641,081,087,911.031,081,087,911.031,081,087,911.03
  期末现金及现金等价物余额976,599,744.621,246,130,604.64974,854,369.211,065,262,838.24
补充资料:
  净利润-807,739,206.52-418,900,671.88
  资产减值准备-6,547,893.55-3,698,807.74
  固定资产和投资性房地产折旧-95,407,662.28-45,656,073.09
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-95,407,662.28-45,656,073.09
  无形资产摊销-6,449,626.04-6,951,793.65
  长期待摊费用摊销-1,689,920.46-828,670.31
  处置固定资产、无形资产和其他长期资产的损失-926,856.07-1,318.95
  固定资产报废损失-1,856,221.03-133,527.18
  公允价值变动损失--485,745.67--250,472.99
  财务费用-6,756,280.51--1,677,906.79
  投资损失--16,938,228.6--7,896,662.55
  递延所得税--11,296,072.18--2,224,916.32
  其中:递延所得税资产减少--12,354,470.89--2,845,399.91
    递延所得税负债增加-1,058,398.71-620,483.59
  存货的减少--111,474,659.7--42,611,877.14
  经营性应收项目的减少--120,855,164.6--179,897.9
  经营性应付项目的增加-269,877,790.74-32,630,221.13
  其他-5,686,840.71--15,537,675.15
  现金的期末余额-1,246,130,604.64-1,065,262,838.24
  减:现金的期初余额-1,081,087,911.03-1,081,087,911.03
  现金及现金等价物的净增加额-165,042,693.61--15,825,072.79
公告日期2026-04-242026-03-252025-10-252025-08-22
审计意见(境内)标准无保留意见
TOP↑